Caption Campaigners and Parkinson's UK staff outside Parliament Local campaigns update 2024 Date 16 December 2024
Parkinson’s UK supports parliamentary debate on mental health support for long-term conditions Date 29 May 2024 We briefed MPs ahead of a parliamentary debate on mental health support for people living with long-term health conditions.
Caption Man and woman at a table looking at a phone and forms Reform of fit notes and Personal Independence Payment Date 2 May 2024 A summary of the changes the UK government is proposing to fit notes and Personal Independence Payment.
Prescription price hike is a barrier to good health and wellbeing Date 2 May 2024 Campaigners are calling for the prescription charge exemption list in England to be reviewed following the price rise.
How UK government plans to monitor bank accounts of benefit claimants will affect people with Parkinson’s Date 18 March 2024 In a move designed to combat welfare benefit fraud and error, the UK government wants the power to instruct banks to provide details of their customer's accounts, even where there is no suspicion of fraud.
Caption Emergency summit on time critical medication Emergency summit on time critical medication Date 15 March 2024 Patient groups, healthcare professionals and NHS England came together to take action to ensure people in hospital get their medication on time, every time.
Caption Representatives from Bechet's UK, Crohn's and Colitis UK, the Cystic Fibrosis Trust, Parkinson's UK, the Pharmacists' Defence Association, the Royal College of GPs and the Royal Pharmaceutical Society outside the Department of Health and Social Care Campaigners call for the prescription charge to be frozen for the next 2 years in England Date 12 March 2024 The Prescription Charges Coalition have handed in a letter signed by over 600 people to freeze the charge at a time when costs are going up.
New treatment for Parkinson’s approved by NICE (The National Institute for Health and Care Excellence) Date 12 March 2024 Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson’s who experience movement related symptoms.
New treatment for Parkinson’s made available on the NHS in England Date 12 March 2024 Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson’s who experience movement related symptoms.
Caption A person taking money out of their wallet Spring budget 2024: a missed opportunity to invest in Parkinson’s before the general election Date 7 March 2024 This week’s spring budget failed to offer much-needed support for people with Parkinson’s.
Caption Older lady sat in a chair reading Still nowhere near enough Date 26 February 2024 At the end of March, the government’s cost of living support will come to an end. Yet our new research has found that for many people with Parkinson’s, the cost of living crisis is far from over.
